My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2024_OpioidSettlemtAgrmt_JanssenJJ
>
Meetings
>
2024
>
04. April
>
2024-04-16 10:00 AM - Commissioners' Agenda
>
2024_OpioidSettlemtAgrmt_JanssenJJ
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/11/2024 1:10:33 PM
Creation date
4/11/2024 1:08:48 PM
Metadata
Fields
Template:
Meeting
Date
4/16/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Accepting the Johnson & Johnson (Janssen) Washington State State-Wide Opioid Settlement Agreement
Order
7
Placement
Consent Agenda
Row ID
116716
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
127
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />16 <br /> <br /> <br />constitute an original counterpart hereof. One or more counterparts of this Agreement may <br />be signed by electronic signature. <br />J. Good Faith and Voluntary Entry. Each Party warrants and represents that it negotiated the <br />terms of this Agreement in good faith. Each of the Parties and signatories to this Agreement <br />warrants and represents that it freely and voluntarily entered into this Agreement without <br />any degree of duress or compulsion. The Parties state that no promise of any kind or nature <br />whatsoever (other than the written terms of this Agreement) was made to them to induce <br />them to enter into this Agreement. <br />K. No Prevailing Party. The Parties each agree that they are not the prevailing party in this <br />action, for purposes of any claim for fees, costs, or expenses as prevailing parties arising <br />under common law or under the terms of any statute, because the Parties have reached a <br />good faith settlement. The Parties each further waive any right to challenge or contest the <br />validity of this Agreement on any ground, including, without limitation, that any term is <br />unconstitutional or is preempted by, or in conflict with, any current or future law. <br />L. Non-Admissibility. The settlement negotiations resulting in this Agreement have been <br />undertaken by the Parties and by certain representatives of the Participating Subdivisions in <br />good faith and for settlement purposes only, and no evidence of negotiations or discussions <br />underlying this Agreement shall be offered or received in evidence in any action or <br />proceeding for any purpose. This Agreement shall not be offered or received in evidence in <br />any action or proceeding for any purpose other than in an action or proceeding arising under <br />or relating to this Agreement. <br />M. Severability. If any provision of this Agreement—excepting Section IV (Release), Section V <br />(Monetary Relief and Payments), Section VII (Participation by Local Governments), Section <br />IX (Attorney Fee and Cost Payments), Section XI.B (Nature of Payment), and Section XI.C <br />(Tax Reporting and Cooperation)—were for any reason held to be invalid, illegal, or <br />unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect <br />any other provision of this Agreement. <br />N. Notices. All notices or other communications under this Agreement shall be in writing <br />(including but not limited to electronic communications) and shall be given to the recipients <br />indicated below: <br />For Janssen: <br /> <br />Charles C. Lifland <br />Daniel R. Suvor <br />O’Melveny & Myers LLP <br />400 South Hope Street, 18th Floor Los Angeles, CA 90071 <br />Phone: (213) 430-6000 <br />clifland@omm.com <br />dsuvor@omm.com <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.